Related references
Note: Only part of the references are listed.Circulating levels of sclerostin are associated with cardiovascular mortality
Cristina Novo-Rodriguez et al.
PLOS ONE (2018)
The association between sclerostin and incident type 2 diabetes risk: a cohort study
O. H. Y. Yu et al.
CLINICAL ENDOCRINOLOGY (2017)
Circulating Serum Irisin Levels in Obesity and Type 2 Diabetes Mellitus
Amira Shoukry et al.
IUBMB LIFE (2016)
Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin
G. Colaianni et al.
CURRENT OSTEOPOROSIS REPORTS (2016)
Protective Effect of Irisin on Atherosclerosis via Suppressing Oxidized Low Density Lipoprotein Induced Vascular Inflammation and Endothelial Dysfunction
Yuzhu Zhang et al.
PLOS ONE (2016)
The myokine irisin increases cortical bone mass
Graziana Colaianni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy
Lin Xiang et al.
ATHEROSCLEROSIS (2014)
Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus
Antonino Catalano et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans
Frode Norheim et al.
FEBS JOURNAL (2014)
Circulating Sclerostin and Irisin Are Related and Interact with Gender to Influence Adiposity in Adults with Prediabetes
Theerawut Klangjareonchai et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Banting Lecture 2012 Regulation of Adipogenesis: Toward New Therapeutics for Metabolic Disease
Bruce M. Spiegelman
DIABETES (2013)
Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
Sonia Morales-Santana et al.
DIABETES CARE (2013)
Sclerostin and bone strength in women in their 10th decade of life
Sara Thorson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Correlates of bone microarchitectural parameters and serum sclerostin levels in men: The STRAMBO study
Pawel Szulc et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Lower circulating irisin is associated with type 2 diabetes mellitus
Jian-Jun Liu et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)
Serum sclerostin levels were positively correlated with fat mass and bone mineral density in Central South Chinese postmenopausal women
Zhifeng Sheng et al.
CLINICAL ENDOCRINOLOGY (2012)
Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women
Aarthi Arasu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults
Karin Amrein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Association of Circulating Sclerostin Levels with Fat Mass and Metabolic Disease-Related Markers in Japanese Postmenopausal Women
Tomohiko Urano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
Antonia Garcia-Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Pontus Bostroem et al.
NATURE (2012)
Wnt4/β-Catenin Signaling Induces VSMC Proliferation and Is Associated With Intimal Thickening
Aikaterini Tsaousi et al.
CIRCULATION RESEARCH (2011)
The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells
Dongxing Zhu et al.
PLOS ONE (2011)
Cellular and molecular mechanisms of vascular injury in diabetes - Part I: Pathways of vascular disease in diabetes
Rosalinda Madonna et al.
VASCULAR PHARMACOLOGY (2011)
Proteomics Characterization of Extracellular Space Components in the Human Aorta
Athanasios Didangelos et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Treatment of dyslipidemia in patients with type 2 diabetes
Krishnaswami Vijayaraghavan
LIPIDS IN HEALTH AND DISEASE (2010)
Adipogenesis and WNT signalling
Constantinos Christodoulides et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Prevalence and control of dyslipidemia among persons with diabetes in the United States
MJ Jacobs et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
KES Poole et al.
FASEB JOURNAL (2005)
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
RL Bezooijen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
A role for the β-catenin/T-cell factor signaling cascade in vascular remodeling
XH Wang et al.
CIRCULATION RESEARCH (2002)
Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia
IS Ismail et al.
DIABETIC MEDICINE (2001)
Share Paper
